Efferon
The Efferon company develops devices with polymer sorbents that help purify the blood during severe conditions of patients with COVID-19
Villach, Austriaefferon.com ↗
Total raised
€4.8M
€4,785,796
Funding rounds
2
Investors
2
distinct backers
Active since
2021-07
latest 2026-05
Funding by year
EUR raised per year · 2026 YTDSignals
Medium confidenceRaise-next likelihood31
base rate 44% for Seed
- ▼ Raised very recently
Exit likelihood12
base rate 12% (2+ rounds)
Timing: too soon vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-05-21 | Seed | €2.5M | Private Investors | View deal → |
| 2021-07-15 | Other | €2.3M | Fix Ventures | View deal → |
Investors
2Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Oura Health€779MFinland · Healthtech
- Doctolib€734MFrance · E-commerce